Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Profound Medical PROF stock holding under pressure Q4 2025 Profit Disappoints PYPD PolyPid posts wider than expected Q4 2025 loss yet shares gain two percent following its latest earnings release CCB Coastal Fin posts 203 Q4 2025 EPS miss shares slip 012 on underwhelming quarterly results ARK Innovation ETF ARKK Cathie Wood Accumulates Meta Platforms META on PostEarnings Dip Amid CapEx and Regulatory Headwinds Waymo Halts Robotaxi Operations in Five US Cities After Flooding Incidents Safety Pause Extended Out of Abundance of Caution Most 401k Participants Over 50 Shun Professional Advice Despite Wanting It Trump Mobile Investigates Potential Data Exposure Affecting Thousands of Prospective Customers Cramers Morning Meeting Buy Sell and a Stock with Potential 30 Upside Wall Streets Rally May Face Headwinds as Earnings Season Concludes and Bond Yields Rise Amazon UK Boss Says Education System Failing to Prepare Youth for Workforce Genasys GNSS Q1 2026 Earnings Strong EPS Surprise of 184 Driven by Profitability RDIB Q3 2025 Earnings EPS Misses Estimates Amid Operational Headwinds NovaBridge Biosciences NBP Q4 2025 Earnings Staggering EPS Miss as PreRevenue Biotech Faces Development Headwinds NVCR Q1 2026 Earnings EPS Misses Estimates by 1852 Despite Positive Stock Movement TEM Q1 2026 Earnings EPS Beats Estimates by 328 Amidst Revenue Data Gap ENDRA Life Sciences Q1 2026 Earnings WiderThanExpected Loss as PreRevenue Biotech Continues Development The Honest Company HNST Edges Higher as Stock Tests Key Resistance Near 385 Roper Technologies ROP Holds Near Key Support as Shares Edge Higher High Roller Technologies ROLR Slips 236 as Stock Tests Key Support Near 512 Marvell Technology Gains Momentum MRVL Approaches Key Resistance After 29 Rally Protalix BioTherapeutics PLX Rises 143 as Biotech Stock Tests Key Resistance